Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report.
Fabry disease is an X-linked recessive glycosphingolipid storage disorder caused by a deficiency of lysosomal enzyme α-galactosidase A. It is recognized that Fabry disease patients often have ventricular arrhythmias. Although the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in patients with ventricular fibrillation is established, there is little evidence regarding ICD therapy for Fabry disease. Here, we report the case of patient with Fabry disease who was treated with an ICD and presented with high defibrillation thresholds.
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Takashi
T
Kanda
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Masaharu
M
Masuda
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Akihiro
A
Sunaga
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Masashi
M
Fujita
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Osamu
O
Iida
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Shin
S
Okamoto
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Takayuki
T
Ishihara
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Kiyonori
K
Nanto
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Tatsuya
T
Shiraki
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Fusako
F
Sera
Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Hyogo, Japan 3-1-69 Inabasou, Amagasaki 660-8511, Japan.
Masaaki
M
Uematsu
Fabry disease; High defibrillation thresholds; Implantable cardioverter-defibrillator; Ventricular fibrillation